As expected from melanoma data, single BRAF inhibitors (i.e., vemurafenib or dabrafenib) induce cell cycle arrest and apoptosis in p.Val600Glu mutated-NSCLC [53]. Here, BRAF is linked to non-small cell lung carcinoma.